FDA Adverse Event Injury Summary report: N

MOBILE CARDIAC OUTPATIENT TELEMETRY PATCH SYSTEM (MCOT)

MDR report key: 8739022 · Received June 27, 2019

Report

Report Number
2133409-2019-00006
Event Type
Injury
Date Received
June 27, 2019
Date of Event
May 25, 2019
Report Date
June 26, 2019
Manufacturer
BRAEMAR MANUFACTURING, LLC
Product Code
DSI
UDI-DI
B146C6S0
PMA / PMN Number
K153473
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
PA, US
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 1

COMPLAINT HANDLING EVALUATION: DHR REVIEW WAS PERFORMED BY BRAEMAR MANUFACTURING, LLC QUALITY ASSURANCE, WITH NO CONTRIBUTING FACTORS IDENTIFIED. IFU PROVIDES WARNING INDICATIONS FOR DISCONTINUING USE AND CONTACTING A MEDICAL PRACTITIONER OR CUSTOMER SERVICE IN THE EVENT THAT SEVERE SKIN IRRITATION OCCURS. PATIENT INDICATED THAT THEY ARE ALLERGIC TO ADHESIVE AND CANNOT WEAR ANY DEVICES THAT HAVE ADHESIVES. MEDICAL AFFAIRS. NO ADDITIONAL INFORMATION IS KNOWN TO BRAEMAR MANUFACTURING, LLC AT THIS TIME.

Description of Event or Problem · 1

ON 28-MAY-2019, BRAEMAR MANUFACTURING, LLC WAS MADE AWARE OF PATIENT ALLEGATION OF BURN/SKIN REACTION. THE PATIENT WORE A C6 PATCH MONITOR AND CONTACTED THEIR HEALTHCARE PROFESSIONAL DUE TO AN ALLEGATION OF BLISTERS AND SKIN IRRITATION. THE PATIENT INDICATED TO THEIR HEALTHCARE PROFESSIONAL THAT THE BURN/SKIN IRRITATION IS VERY SERIOUS AND THAT IT IS A THIRD DEGREE BURN. THE HEALTHCARE PROFESSIONAL CONTACTED THEIR ACCOUNT EXECUTIVE CONTACT AND NOTIFIED OF THE EVENT, INDICATING THAT THEY DO NOT BELIEVE THAT THE SKIN IRRITATION/BURN IS SERIOUS. NOTE: THE BECOME AWARE OF THE EVENT FOR LIFEWATCH SERVICES, INC. AND BRAEMAR MANUFACTURING IS 28-MAY-2019, BASED ON NOTIFICATION DATE BY THE INITIAL REPORTER LISTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
533754 MOBILE CARDIAC OUTPATIENT TELEMETRY PATCH SYSTEM (MCOT) MOBILE CARDIAC OUTPATIENT TELEMETRY PATCH SYSTEM (MCOT) DSI BRAEMAR MANUFACTURING, LLC 900-0634-00 B146C6S0

Patients

Seq Age Sex Outcome Treatment
1 27 YR Other